Previous 10 | Next 10 |
MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced changes to its board of directors and execut...
~ Revenue of $16.0 million, Including Net Product Sales of $13.8 million, for the Second Quarter 2019 ~ ~ Reduction of Operating Expenses of 32 Percent, or $16.3 million, Year-Over-Year ~ ~ Commenced Enrollment in Clinical Trial Evaluating Orbactiv ® (oritavancin) Shorte...
~ Second Quarter 2019 Financial Results to be Reported on Friday, August 9, 2019 ~ ~ Company Cancels Previously Scheduled Earnings Call ~ MORRISTOWN, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the develo...
Gainers: ABMD +5.7% . OBLN +5.6% . ACOR +5.1% . ERIC +4.2% . More news on: Abiomed, Inc., Obalon Therapeutics, Inc., Acorda Therapeutics, Inc., Stocks on the move, , News on ETFs Read more ...
Immuron (NASDAQ: IMRN ) +134% on revenue surge . More news on: Immuron Limited, Neovasc Inc., Bio-Path Holdings, Inc., Stocks on the move, Read more ...
Melinta Therapeutics (NASDAQ: MLNT ) has reported preliminary Q2 results and provided a corporate update. More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
~ Expects to Report Second Quarter 2019 Net Product Sales of Approximately $13.8 Million, Which Represents an Increase of 17 Percent Over the First Quarter of 2019 ~ ~ Anticipates Having Approximately $90 Million of Cash and Cash Equivalents on Hand at the End of the Second Qua...
Gainers: HELE +7.4% . WDFC +3.5% . OCX +1.5% . MLNT +1.4% . AUO +1.4% . More news on: Helen of Troy Limited, WD-40 Company, OncoCyte Corporation, Stocks on the move, Read more ...
Gainers: OMNOVA Solutions (NYSE: OMN ) +55% . SELLAS Life Sciences Group (NASDAQ: SLS ) +46% . Karyopharm Therapeutics (NASDAQ: KPTI ) +36% . One Stop Systems (NASDAQ: OSS ) +26% . NIO (NYSE: NIO ) +15% . Corvus Pharmaceuticals (NASDAQ: CRVS ) +15% . Melinta Therapeutics (NASDA...
Citing a "lack of clarity" regarding its ability to meet certain requirements under its loan with Vatera Investment Partners LLC, Melinta Therapeutics (NASDAQ: MLNT ) discloses that it will unable to draw additional funds under the $135M loan. More news on: Melinta Therapeutics, Inc., He...
News, Short Squeeze, Breakout and More Instantly...
Melinta Therapeutics Inc - Ordinary Shares Company Name:
MLNT Stock Symbol:
NASDAQ Market:
Melinta Therapeutics Inc - Ordinary Shares Website:
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. (“Purch...
Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotic...
Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company Continues Operations with No Anticipated Disruption to Product Supply or Support MO...